HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Fate Therapeutics, Inc provides biotechnology services. The company researches and develops therapies to repair and regenerate body tissues with the help of stem cells.
Market Cap | 6.804 Billion | Shares Outstanding | 87.244 Million | Avg 30-day Volume | 1.076 Million | ||
P/E Ratio | Dividend Yield | EPS | |||||
Price/Sales | Debt to Equity | EBITDA | |||||
Price to Book Value | 0.0 | Forward PE | -41.99 | Enterprise Value | |||
Total Cash | Current Debt | Gross Profit | |||||
BETA | 1.58481 | 52-week High/Low | 121.16 / 25.6 | Next Earnings Date | 2021-05-04 | Price to Cash FLow (P/CF) | -9999999.0 |
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 12 | 8 | 50.0% | 4 (0.24%) | 5 (0.31%) | -20.0% |
Funds Holding: | 245 | 211 | 16.11% | 82 (4.93%) | 74 (4.61%) | 10.81% |
13F shares: | 86.677 Million | 86.934 Million | -0.3% | 33.728 Million | 33.684 Million | 0.13% |
% Ownership | 99.3496 | 99.6447 | -0.3% | 38.6596 | 38.6094 | 0.13% |
New Positions: | 64 | 29 | 120.69% | 22 | 15 | 46.67% |
Increased Positions | 70 | 87 | -19.54% | 19 | 28 | -32.14% |
Closed Positions | 28 | 20 | 40.0% | 14 | 13 | 7.69% |
Reduced Positions | 93 | 64 | 45.31% | 35 | 23 | 52.17% |
Total Calls | 277.869 Thousand | 267.408 Thousand | 3.91% | 103.24 Thousand | 99.1 Thousand | 4.18% |
Total Puts | 208.946 Thousand | 180.669 Thousand | 15.65% | 120.141 Thousand | 79.954 Thousand | 50.26% |
PUT/CALL Ratio | 0.75 | 0.68 | 10.29% | 1.16 | 0.81 | 43.21% |
Heat Map Ranking | 40 | |||||
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
100 Thousand total shares from 26 transactions
75 Thousand total shares from 4 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
TAHL CINDY SEE REMARKS |
|
118,506 | 2021-04-01 | 7 |
CHU YU-WAYE SEE REMARKS |
|
68,075 | 2021-03-24 | 1 |
VALAMEHR BAHRAM CHIEF DEVELOPMENT OFFICER |
|
111,896 | 2021-03-15 | 5 |
SHOEMAKER DANIEL D CHIEF SCIENTIFIC OFFICER |
|
73,020 | 2021-03-08 | 5 |
WOLCHKO J SCOTT PRESIDENT AND CEO |
|
393,793 | 2021-02-18 | 5 |
DULAC EDWARD J III CHIEF FINANCIAL OFFICER |
|
58,013 | 2021-01-20 | 3 |
|
12,957,222 | 2021-01-08 | 2 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 1 | |
|
0 | 2020-05-01 | 2 | |
|
2,310,432 | 2019-07-31 | 0 | |
ABBOT STEWART CHIEF DEVELOPMENT OFFICER |
|
64,917 | 2018-05-15 | 0 |
STORGARD CHRIS CHIEF MEDICAL OFFICER |
|
0 | 2018-01-16 | 0 |
|
0 | 2017-05-02 | 0 | |
FATE THERAPEUTICS INC CHIEF SCIENTIFIC OFFICER |
|
103,816 | 2016-01-08 | 0 |
WEYER CHRISTIAN SEE REMARKS |
|
30,429 | 2015-04-13 | 0 |
MULTANI PRATIK S CHIEF MEDICAL OFFICER |
|
3,024 | 2015-01-05 | 0 |
FLYNN PETER D SEE REMARKS |
|
6,505 | 2015-01-05 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-04-02 18:03:43 -0400 | 2021-04-01 | M | 28,149 | d | 0 | direct | yes | |||||||||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 4,835 | $85.98 | d | 113,747 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 4,556 | $82.69 | d | 124,272 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | M | 1,851 | $7.87 | a | 138,048 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 400 | $87.45 | d | 108,048 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 2,200 | $84.48 | d | 118,582 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 8,220 | $81.48 | d | 128,828 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | M | 28,149 | $2.90 | a | 136,197 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | M | 1,851 | d | 10,458 | direct | yes | |||||||||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 5,299 | $86.76 | d | 108,448 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 3,490 | $83.40 | d | 120,782 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-04-02 18:03:43 -0400 | 2021-04-01 | S | 1,000 | $80.49 | d | 137,048 | direct | yes | -4.2553 | -10.3514 | 0.0 | 1 | -10.3514 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | S | 1,018 | $94.59 | d | 95,740 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | S | 8,416 | $91.94 | d | 108,367 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | S | 3,205 | $93.75 | d | 96,758 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | S | 3,957 | $90.89 | d | 116,783 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | M | 25,000 | d | 16,156 | direct | yes | |||||||||
2021-03-16 16:05:19 -0400 | 2021-03-15 | S | 8,404 | $92.64 | d | 99,963 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-16 16:05:19 -0400 | 2021-03-15 | M | 25,000 | $2.90 | d | 120,740 | direct | yes | -6.3201 | -10.668 | 0.1635 | 4 | -10.668 | 6 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 800 | $86.70 | d | 73,020 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 2,480 | $83.46 | d | 79,448 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 4,627 | $79.58 | d | 90,095 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 2,900 | $85.50 | d | 73,820 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 2,993 | $81.60 | d | 81,928 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 3,298 | $78.60 | d | 94,722 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 2,728 | $84.20 | d | 76,720 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-03-09 16:02:06 -0500 | 2021-03-08 | S | 5,174 | $80.73 | d | 84,921 | direct | yes | 8.6923 | 2.1369 | 8.6923 | 2 | -0.1336 | 5 | ||
2021-02-19 16:07:51 -0500 | 2021-02-18 | M | 20,000 | $6.62 | a | 413,793 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 | |
2021-02-19 16:07:51 -0500 | 2021-02-18 | S | 5,547 | $103.16 | d | 393,793 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 | |
2021-02-19 16:07:51 -0500 | 2021-02-18 | S | 1,848 | $100.48 | d | 410,544 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 | |
2021-02-19 16:07:51 -0500 | 2021-02-18 | S | 8,602 | $102.26 | d | 399,340 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 | |
2021-02-19 16:07:51 -0500 | 2021-02-18 | S | 1,401 | $99.08 | d | 412,392 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 | |
2021-02-19 16:07:51 -0500 | 2021-02-18 | M | 20,000 | d | 14,846 | direct | yes | |||||||||
2021-02-19 16:07:51 -0500 | 2021-02-18 | S | 2,602 | $101.42 | d | 407,942 | direct | yes | -5.4279 | -4.3086 | -20.6616 | 0.0 | 1 | -28.5261 | 25 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
FATE THERAPEUTICS INC FATE | 2021-04-14 22:15:03 UTC | -0.1943 | 0.2543 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 21:45:03 UTC | -0.1919 | 0.2519 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 21:15:03 UTC | -0.1919 | 0.2519 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 20:45:03 UTC | -0.1902 | 0.2502 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 20:15:04 UTC | -0.1902 | 0.2502 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 19:45:03 UTC | -0.1902 | 0.2502 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 19:15:03 UTC | -0.1902 | 0.2502 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 18:45:02 UTC | -0.1937 | 0.2537 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 18:15:03 UTC | -0.1937 | 0.2537 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 17:45:03 UTC | -0.1937 | 0.2537 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 17:15:03 UTC | -0.1937 | 0.2537 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 16:45:03 UTC | -0.1945 | 0.2545 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 16:15:03 UTC | -0.1945 | 0.2545 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 15:45:03 UTC | -0.1945 | 0.2545 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 15:15:03 UTC | -0.1945 | 0.2545 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 14:45:02 UTC | -0.19 | 0.25 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 14:15:03 UTC | -0.19 | 0.25 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 13:45:03 UTC | -0.19 | 0.25 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 13:15:03 UTC | -0.19 | 0.25 | 700000 |
FATE THERAPEUTICS INC FATE | 2021-04-14 12:45:03 UTC | -0.19 | 0.25 | 700000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund | FATE | -1109.0 shares, $-100841.37 | 2020-12-31 | N-PORT |
LoCorr Investment Trust- LoCorr Dynamic Equity Fund | FATE | -256.0 shares, $-23278.08 | 2020-12-31 | N-PORT |
Trust for Professional Managers- Convergence Market Neutral Fund | FATE | -1793.0 shares, $-65265.2 | 2020-08-31 | N-PORT |
FundVantage Trust- Gotham Hedged Plus Fund | FATE | -406.0 shares, $-36917.58 | 2020-12-31 | N-PORT |
FundVantage Trust- Gotham Defensive Long Fund | FATE | -75.0 shares, $-1665.75 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | FATE | -22.0 shares, $-488.62 | 2020-03-31 | N-PORT |
RUSSELL INVESTMENT CO- Sustainable Equity Fund | FATE | -726.0 shares, $-65797.38 | 2021-01-31 | N-PORT |
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund | FATE | -972.0 shares, $-88092.36 | 2021-01-31 | N-PORT |